It is critical that researchers gather evidence of factors that identify infants at risk of out-of-home placement based on types of substance exposures and demographic characteristics. This study applied a validated medical record data extraction tool on data derived from a multi-site (N = 30) pediatric clinical trials network (ISPCTN) study of Neonatal Opioid Withdrawal (ACT NOW study). Participants included 1808 birthing parent-infant dyads with documented NOWS scoring or prenatal opioid exposure. Non-Hispanic White pregnant persons comprised the largest proportion of the sample (69.8%), followed by Non-Hispanic Black (11.6%), Non-Hispanic Multiracial and Other race (8.5%), and Hispanic (6.2%). Most notably, infant prenatal substance exposure across alcohol, cocaine, meth/amphetamine, and opioids, had the lowest possibility of discharging to parent(s). Additionally, latent class analysis identified distinct classes of substance use during pregnancy that were associated with different probabilities of discharging to parent(s). Specifically, less than half of infants (47%–49%) in the Poly-use and Meth/amphetamine classes were discharged to their parent(s). Severity of infant withdrawal symptoms influenced placement decisions within the Poly-use and Prescription Opioid classes. Findings can inform standard practices for increasing support for pregnant persons and substance-exposed infants including identification, subsequent referrals, communication with Child Protective Services, and plans of safe care.
AsparouhovT.MuthénB. (2021). Advances in Bayesian model fit evaluation for structural equation models. Structural Equation Modeling: A Multidisciplinary Journal, 28(1), 1–14. https://doi.org/10.1080/10705511.2020.1764360
2.
AustinA. E.GestC.AtkesonA.BerkoffM. C.PulsH. T.ShanahanM. E. (2022). Prenatal substance exposure and child maltreatment: A systematic review. Child Maltreatment, 27(2), 290–315. https://doi.org/10.1177/1077559521990116
3.
BakhirevaL. N.HolbrookB. D.ShresthaS.LeyvaY.AshleyM.CanoS.LoweJ.StephenJ. M.LeemanL. (2019). Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5–8 months of age. Early Human Development, 128(2019), 69–76. https://doi.org/10.1016/j.earlhumdev.2018.10.010
4.
BenjaminiY.HochbergY. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B, 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
5.
BolckA.CroonM.HagenaarsJ. (2004). Estimating latent structure models with categorical variables: One-step versus three-step estimators. Political Analysis, 12(1), 3–27. https://doi.org/10.1093/pan/mph001
6.
BronfenbrennerU. (1994). Ecological models of human development. International Encyclopedia of Education, 3(2), 37–43.
7.
CanfieldM.RadcliffeP.MarlowS.BorehamM.GilchristG. (2017). Maternal substance use and child protection: A rapid evidence assessment of factors associated with loss of child care. Child Abuse & Neglect, 70(2017), 11–27. https://doi.org/10.1016/j.chiabu.2017.05.005
8.
CarlsonB. E.WilliamsL. R.ShaferM. S. (2012). Methamphetamine-involved parents in the child welfare system: Are they more challenging than other substance-involved parents?Journal of Public Child Welfare, 6(3), 280–295. https://doi.org/10.1080/15548732.2012.683361
9.
Carrillo BeckR.SzlapinskiJ.PachecoN.Sabri LaghaeiS.IsardR.OudshoornA.MarshallC. A. (2022). Violence and victimisation in the lives of persons experiencing homelessness who use methamphetamine: A scoping review. Health and Social Care in the Community, 30(5), 1619–1636. https://doi.org/10.1111/hsc.13716
10.
ClaryE.RibarC.WeigensbergE.RadelL.MaddenE. (2020). Challenges in providing substance use disorder treatment to child welfare clients in rural communities. US Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation.
11.
CummingsJ. R.WenH.KoM. (2016). Decline in public substance use disorder treatment centers most serious in counties with high shares of black residents. Health Affairs, 35(6), 1036–1044. https://doi.org/10.1377/hlthaff.2015.1630
12.
DevlinL. A.HuZ.OunpraseuthS.SimonA. E.AnnettR. D.DasA.FullerJ. F.HigginsR. D.MerharS. L.SmithP. B.CrawfordM. M.CottrellL. E.CzynskiA. J.NewmanS.PaulD. A.SánchezP. J.SemmensE. O.SmithM. C.WhalenB. L.YoungL. W. (2023). The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome. Maternal and Child Health Journal, 27(6), 1030–1042. https://doi.org/10.1007/s10995-022-03521-3
13.
EllsworthM. A.StevensT. P.D'AngioC. T. (2010). Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns. Pediatrics, 125(6), e1379–e1385. https://doi.org/10.1542/peds.2008-3525
14.
GandhiK. D.SchakK. M.VandeJ. L.ShekunovJ.LynchB. A.RummansT. A.GeskeJ. R.PeaseE. R.LimbeckM. G.DesaiJ.CroarkinP. E.RomanowiczM. (2021). The negative impact of maternal perinatal opioid use on neonatal outcomes. The Primary Care Companion for CNS Disorders, 23(3), 20m02737. https://doi.org/10.4088/PCC.20m02737
15.
GfroererJ. C.LarsonS. L.ColliverJ. D. (2007). Drug use patterns and trends in rural communities. The Journal of Rural Health, 23(Suppl), 10–15. https://doi.org/10.1111/j.1748-0361.2007.00118.x
16.
GissandanerT. D.WenA.GetteJ. A.PerryK. J.MutignaniL. M.ReganT.MallochL.TuckerL. C.WhiteC. B.FryT. B.LimC. S.AnnettR. D. (2024). Considerations and determinants of discharge decisions among prenatal substance exposed infants. Child Maltreatment, 29(2), 246–258. https://doi.org/10.1177/10775595231161996
17.
HenkhausL. E.BuntinM. B.HendersonS. C.LaiP.PatrickS. W. (2022). Disparities in receipt of medications for opioid use disorder among pregnant women. Substance Abuse, 43(1), 508–513. https://doi.org/10.1080/08897077.2021.1949664
18.
HiraiA. H.KoJ. Y.OwensP. L.StocksC.PatrickS. W. (2021). Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA, 325(2), 146–155. https://doi.org/10.1001/jama.2020.24991
19.
KeppleN. J. (2017). The complex nature of parental substance use: Examining past year and prior use behaviors as correlates of child maltreatment frequency. Substance Use & Misuse, 52(6), 811–821. https://doi.org/10.1080/10826084.2016.1253747
20.
KerkerB. D.HorwitzS. M.LeventhalJ. M. (2004). Patients’ characteristics and providers’ attitudes: Predictors of screening pregnant women for illicit substance use. Child Abuse & Neglect, 28(2), 209–223. https://doi.org/10.1016/j.chiabu.2003.07.004
21.
LynchS.ShermanL.SnyderS. M.MattsonM. (2018). Trends in infants reported to child welfare with neonatal abstinence syndrome (NAS). Children and Youth Services Review, 86(2018), 135–141. https://doi.org/10.1016/j.childyouth.2018.01.035
22.
Maguire-JackK.JespersenB.KorbinJ. E.SpilsburyJ. C. (2021). Rural child maltreatment: A scoping literature review. Trauma, Violence, & Abuse, 22(5), 1316–1325. https://doi.org/10.1177/1524838020915592
23.
MenyhartO.WeltzB.GyőrffyB. (2021). MultipleTesting. com: A tool for life science researchers for multiple hypothesis testing correction. PLoS One, 16(6), Article e0245824. https://doi.org/10.1371/journal.pone.0245824
24.
MessinaN.JeterK.Marinelli-CaseyP.WestK.RawsonR. (2014). Children exposed to methamphetamine use and manufacture. Child Abuse & Neglect, 38(11), 1872–1883. https://doi.org/10.1016/j.chiabu.2006.06.009
25.
Murphy-OikonenJ. (2021). Neonatal abstinence syndrome: Decisions concerning infant safety. Journal of Public Child Welfare, 15(3), 384–411. https://doi.org/10.1080/15548732.2020.1733731
PalusciV. J.BotashA. S. (2021). Race and bias in child maltreatment diagnosis and reporting. Pediatrics, 148(1), Article e2020049625. https://doi.org/10.1542/peds.2020-049625
28.
PatrickS. W.FrankR. G.McNeerE.SteinB. D. (2019). Improving the child welfare system to respond to the needs of substance-exposed infants. Hospital Pediatrics, 9(8), 651–654. https://doi.org/10.1542/hpeds.2019-0106
29.
PatrickS. W.SchumacherR. E.BenneyworthB. D.KransE. E.McAllisterJ. M.DavisM. M. (2012). Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA, 307(18), 1934–1940. https://doi.org/10.1001/jama.2012.3951
30.
Peacock-ChambersE.LeyenaarJ. K.FossS.FeinbergE.WilsonD.FriedmannP. D.VisintainerP.SinghR. (2019). Early intervention referral and enrollment among infants with neonatal abstinence syndrome. Journal of Developmental and Behavioral Pediatrics: JDBP, 40(6), 441–450. https://doi.org/10.1097/DBP.0000000000000679
31.
PrindleJ. J.HammondI.Putnam-HornsteinE. (2018). Prenatal substance exposure diagnosed at birth and infant involvement with child protective services. Child Abuse & Neglect, 76(2018), 75–83. https://doi.org/10.1016/j.chiabu.2017.10.002
32.
Putnam-HornsteinE.PrindleJ. J.LeventhalJ. M. (2016). Prenatal substance exposure and reporting of child maltreatment by race and ethnicity. Pediatrics, 138(3), Article e20161273. https://doi.org/10.1542/peds.2016-1273
33.
RebbeR.MienkoJ. A.BrownE.Rowhani-RahbarA. (2019). Child protection reports and removals of infants diagnosed with prenatal substance exposure. Child Abuse & Neglect, 88(2019), 28–36. https://doi.org/10.1016/j.chiabu.2018.11.001
34.
RommelN.RohlederN. H.WagenpfeilS.Haertel-PetriR.KestingM. R. (2015). Evaluation of methamphetamine-associated socioeconomic status and addictive behaviors, and their impact on oral health. Addictive Behaviors, 50(2015), 182–187. https://doi.org/10.1016/j.addbeh.2015.06.040
WinkelmanT. N.VillapianoN.KozhimannilK. B.DavisM. M.PatrickS. W. (2018). Incidence and costs of neonatal abstinence syndrome among infants with medicaid: 2004–2014. Pediatrics, 141(4), Article e20173520. https://doi.org/10.1542/peds.2017-3520
YoungL. W.HuZ.AnnettR. D.DasA.FullerJ. F.HigginsR. D.LesterB. M.MerharS. L.SimonA. E.OunpraseuthS.SmithP. B.CrawfordM. M.AtzA. M.CottrellL. E.CzynskiA. J.NewmanS.PaulD. A.SánchezP. J.SemmensE. O.Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network and the Nih Environmental Influences on Child Health Outcomes Echo Program Institutional Development Awards States Pediatric Clinical Trials Network. (2021). Site-level variation in the characteristics and care of infants with neonatal opioid withdrawal. Pediatrics, 147(1), Article e2020008839. https://doi.org/10.1542/peds.2020-008839
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
